CD276 and glioblastoma: The immune checkpoint molecule B7 homolog 3 (B7-H3, CD276) functions predominantly as an inhibitory regulator of T-cell-mediated antitumor responses and is highly, selectively overexpressed in most GBM, where expression correlates with grade and poor prognosis 56.